Scilex Holding Co

Scilex Holding Company, a specialty pharmaceutical firm focused on non-opioid pain management therapeutics, filed an 8-K current report with the Securities and Exchange Commission on July 23, 2025, under the ticker VCKA on Nasdaq. The company entered public markets through its merger with Vickers Vantage Corp. I, a blank-check vehicle that completed its initial public offering in 2021 and was sponsored by Vickers Capital Group. The SPAC targeted the healthcare and life sciences sector prior to completing its business combination with Scilex. Post-merger, the company maintains its SEC reporting obligations as a publicly traded specialty pharmaceutical issuer. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal analytics on VCKA and the broader SPAC universe.